Home Op-Ed | Opinion

Op-Ed | Opinion

Op-Ed | Opinion

New Technologies in Post-surgical Wound Dressings

Brad Greer, JD - January 16, 2023

The Patient Journey Tech Stack: 10 Predictions for 2023

Rural healthcare providers face a host of unique challenges that force physicians, nurses, and hospital administrators to think creatively in order to deliver the highest quality care possible to patients.

Advancing Health Equity for Oncology Patients

Congress Should Increase Access to Prostate Cancer Care for Veterans

Project Optimus: How to Prepare for Success

The Dictatorship of Cancer: How to Topple it in Three –...

Bryan Oronsky, MD. Ph.D. - October 21, 2022

Doctor discussing treatment options with a patient.

Is Finding a Donor for All in Need of Allogeneic HCT...

Stephen Spellman, MBS - September 5, 2022

Right to Know: The Critical Importance of Options and Choices in...

Alpesh Desai D.O. - August 11, 2022

Using Bayesian Designs to Inform Dose Recommendations in Clinical Trials

Edward Matthews - August 10, 2022

Alleviating Targeted Therapy Side Effects: Essential for Patient QOL and Best...

Kathleen Kiernan Harnden, MD - June 8, 2022

What can we do to Better Manage our Pharmaceutical Waste?

Frithjof Laubinger - June 6, 2022

An Rx for American Healthcare: More Physician Entrepreneurship

Steven J. Cyr, MD - June 1, 2022

Combating Financial Hurdles: Setting up Physicians for Short- and Long-term Financial...

Charlie Nemes - May 18, 2022

Bioimpedance Spectroscopy Better than Tape Measure for Preventing Breast Cancer-Related Lymphedema

Sheila Ridner, PhD, RN, FAAN - May 13, 2022

Cancer Moonshot Funding Should Focus on Prevention Not just Cure or...

Insoo Park - May 12, 2022

12 3...8 Page 1 of 8

LATEST NEWS

US FDA Approves Gilead’s Sacituzumab Govitecan In Pre-treated HR+/HER2- Metastatic Breast Cancer

Editorial Team - February 3, 2023

World health Organization Launches a New Global Breast Cancer Initiative

Editorial Team - February 3, 2023

A New Design Improves CAR-based Immunotherapies

Editorial Team - February 2, 2023

Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival

Danielle Garcia - January 27, 2023

Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...

Editorial Team - January 18, 2023

Press Releases | Cancer

New treatment approach for prostate cancer could stop resistance in... February 3, 2023
For the first time, researchers from Sanford Burnham Prebys have discovered that prostate cancer can be killed by targeting a single enzyme. The findings could help address the growing threat of...(PRWeb February 03, 2023)Read the full story at https://www.prweb.com/releases/new_treatment_approach_for_prostate_cancer_could_stop_resistance_in_its_tracks/prweb19152889.htm
Mays Cancer Center led studies of innovative breast cancer drug that... February 1, 2023
The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for...(PRWeb February 01, 2023)Read the full story at https://www.prweb.com/releases/mays_cancer_center_led_studies_of_innovative_breast_cancer_drug_that_recently_gained_fda_approval/prweb19145026.htm
UMC Health System Adopts MOLLI Technology to Provide Highest Level of... January 31, 2023
One of Texas’ leading doctors turns to breakthrough technology to deliver an improved experience and better outcomes for breast cancer patients.(PRWeb January 31, 2023)Read the full story at https://www.prweb.com/releases/umc_health_system_adopts_molli_technology_to_provide_highest_level_of_care_for_breast_cancer_patients/prweb19137969.htm